Dennis Cho - 13 Sep 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Senior Vice President, General Counsel, and Chief Ethics and Compliance Officer.
Signature
/s/ William Solis, as Attorney-in-Fact for Dennis Cho
Issuer symbol
TWST
Transactions as of
13 Sep 2021
Net transactions value
$0
Form type
4
Filing time
16 Sep 2021, 16:49:43 UTC
Next filing
29 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +4,097 $0.000000 4,097 13 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Award $0 +8,194 $0.000000 8,194 13 Sep 2021 Common Stock 8,194 $115.93 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award ("RSU") of which 25% of the total number of RSUs vest on the first anniversary of September 13, 2021 and 1/16th of the total number of RSUs vest on each quarterly anniversary thereafter, for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.
F2 25% of the shares subject to the option vest and become exercisable on the one (1) year anniversary of September 13, 2021 and 1/48 of the shares subject to the option vest and become exercisable monthly thereafter, subject to the Reporting Person's continuous service through each vesting date.

Remarks:

Senior Vice President, General Counsel, and Chief Ethics and Compliance Officer.